97793711 - INBIO RESEARCH MADE REAL

Information

  • Trademark
  • 97793711
  • Serial Number
    97793711
  • Registration Number
    7425182
  • Filing Date
    February 14, 2023
    a year ago
  • Registration Date
    June 25, 2024
    7 months ago
  • Transaction Date
    June 25, 2024
    7 months ago
  • Status Date
    June 25, 2024
    7 months ago
  • Published for Opposition Date
    April 09, 2024
    10 months ago
  • Location Date
    June 24, 2024
    7 months ago
  • First Use Anywhere Date
    March 01, 2022
    2 years ago
  • First Use In Commerce Date
    March 01, 2022
    2 years ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    MICKLEBURGH, LINDA BOH
  • Attorney Name
    Michael J. Hertz
  • Owners
Mark Drawing Code
3
Mark Identification
INBIO RESEARCH MADE REAL
Case File Statements
  • GS0411: Education services, namely, providing training courses in the fields of allergy, immunology and life sciences
  • DM0000: The mark consists of the word "inbio" in lower case and a stylized font. To the left of the word "inbio" is a shaded circle and the second "i" in "inbio" is upside down. Below the word "inbio" is the phrase "Research made real".
  • GS0051: Medical diagnostic assay preparations for testing of body fluids; medical diagnostic reagents and assays for testing body fluids, composed of antibodies for detection of antibodies in blood and other body fluids; diagnostic kits consisting primarily of antibodies, buffers and reagents for use in disease testing, namely, for diagnosis of allergic diseases
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Diagnostic assay preparations for scientific or research use; antibodies for scientific or research use or for use in the manufacture of allergen detection systems, devices and allergen purification systems; antibodies for clinical or medical laboratory use or for environmental analysis, namely, analysis of the exposure to allergens, all for use in the diagnosis of allergic diseases, including rhinitis, asthma, atopic dermatitis, food allergies and occupational allergies; biochemicals, namely, antibodies and allergens for scientific or research use; biochemicals in the nature of antibodies and allergens used in the manufacture of allergen detection systems and devices and allergen purification systems; assays for research purposes, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances; diagnostic assays for research purposes, composed of antibodies, for detection and measurement of allergen concentrations in indoor and outdoor environments, or in dust, air, foods, or any other substances; diagnostic kits consisting primarily of antibodies, buffers, and reagents to monitor allergen concentrations in indoor and outdoor environments, or in dust, air, foods or any other substances, antibodies in blood and other body fluids
  • GS0441: Providing medical information regarding the health effects of environmental allergens, molds and bacterial products, their effects on indoor air quality, associated diseases, and exposure assessment and risk factors
  • GS0101: Medical diagnostic instruments for the analysis of body fluids, namely, diagnostic instruments composed of plastic microtiter plates, nitrocellulose membranes, affinity matrices and microbeads, for detection of antibodies in blood and other body fluids; medical apparatus and instruments, composed of plastic microtiter plates, antibody immunoadsorbents prepared using agarose beads, agarose and acrylamide gels, plastic laboratory columns and tubing, for isolation and purification of natural and recombinant allergens for diagnosis and treatment of allergic diseases; medical apparatus and instruments, composed of plastic dust collection devices with membrane filters, plastic microtiter plates, plastic cassettes containing antibody coated membranes, and dipsticks for use in diagnosis and treatment of allergic diseases
Case File Event Statements
  • 2/17/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 3/3/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/4/2023 - a year ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 11/8/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/9/2023 - a year ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 11/9/2023 - a year ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 11/9/2023 - a year ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 12/13/2023 - a year ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/1/2024 - 11 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/1/2024 - 11 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/1/2024 - 11 months ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/20/2024 - 10 months ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/9/2024 - 10 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/25/2024 - 7 months ago
    15 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 6/25/2024 - 7 months ago
    16 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 4/9/2024 - 10 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB